Orient Europharma Co (ROCO:4120) Net Change in Cash : NT$-301 Mil (TTM As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Orient Europharma Co's Net Change in Cash for the three months ended in Dec. 2024 was NT$-21 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-301 Mil.

Orient Europharma Co Net Change in Cash Historical Data

The historical data trend for Orient Europharma Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co Net Change in Cash Chart

Orient Europharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

369.22

-162.09

-158.28

-64.91

-301.03

Orient Europharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-119.72	-177.29	-161.72	58.60	-20.62

Orient Europharma Co Net Change in Cash Calculation

Orient Europharma Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-121.108	+	465.2	+	-760.917	+	115.797
	=	-301

Orient Europharma Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 97.757 + 658.713 + -791.295 + 14.201

= -21

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-301 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orient Europharma Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Orient Europharma Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Europharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » Net Change in Cash

Comparable Companies

TPE:4108 TPE:1731 ROCO:4747 ROCO:6932 ROCO:4132 ROCO:1796 ROCO:8432 TPE:3054 ROCO:4127 ROCO:1780 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692

Traded in Other Exchanges

N/A

Address

13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052

Website

https://www.oepgroup.com

Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines